Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors

Neuroscience Letters

Volumn 378, Issue 3, 2005, Pages 131-134

  Kawashima, Naoya ^a   Karasawa, Jun Ichi ^a   Shimazaki, Toshiharu ^a   Chaki, Shigeyuki ^a   Okuyama, Shigeru ^a   Yasuhara, Akito ^a   Nakazato, Atsuro ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Antidepressant; Electrophysiology; Group II metabotropic glutamate receptor; MGS0039; Serotonergic neuron

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 AMINO 3 (3,4 DICHLOROBENZYLOXY) 6 FLUOROBICYCLO[3.1.0]HEXANE 2,6 DICARBOXYLIC ACID; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFECT; ELECTROPHYSIOLOGY; LOCUS CERULEUS; MALE; MICRODIALYSIS; MONOAMINE NERVE CELL; NEUROPHARMACOLOGY; NONHUMAN; NORADRENERGIC NERVE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL;

EID: 15244341953     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.12.021     Document Type: Article

References (20)

1. G.K. Aghajanian, and G.J. Marek Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells Neuropharmacology 36 1997 589 599
2. J.M. Baraban, and G.K. Aghajanian Suppression of serotonergic neuronal firing by alpha-adrenoceptor antagonists: evidence against GABA mediation Eur. J. Pharmacol. 66 1980 287 294
3. J. Cartmell, J.A. Monn, and D.D. Schoepp Attenuation of specific PCP-evoked behaviors by the potent mGluR2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine Psychopharmacology 148 2000 423 429
4. J. Cartmell, and D.D. Schoepp Regulation of neurotransmitter release by metabotropic glutamate receptors J. Neurochem. 75 2000 889 907
5. S. Chaki, R. Yoshikawa, S. Hirota, T. Shimazaki, M. Maeda, N. Kawashima, T. Yoshimizu, A. Yasuhara, K. Sakagami, S. Okuyama, S. Nakanishi, and A. Nakazato MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity Neuropharmacology 46 2004 457 467
6. P.J. Conn, and J.P. Pin Pharmacology and functions of metabotropic glutamate receptors Annu. Rev. Pharmacol. Toxicol. 37 1997 205 237
7. W. Danysz, C.G. Parsons, I. Bresink, and G. Quack Glutamate in CNS disorders Drug News Perspect. 8 1995 261 277
8. M.J. Detke, M. Rickels, and I. Lucki Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants Psychopharmacology 121 1995 66 72
9. A.W. Graham, and G.K. Aghajanian Effects of amphetamine on single cell activity in a catecholamine nucleus, the locus coeruleus Nature 234 1971 100 102
10. C. Grillon, J. Cordova, L.R. Levine, and C.A. Morgan 3rd. Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans Psychopharmacology 168 2003 446 454
11. D.R. Helton, J.P. Tizzano, J.A. Monn, D.D. Shoepp, and M.J. Kallman Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors J. Pharmacol. Exp. Ther. 284 1998 651 660
12. E. Jodo, C. Chiang, and G. Aston-Jones Potent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons Neuroscience 83 1998 63 79
13. J.E. Malberg, A.J. Eisch, E.J. Nestler, and R.S. Duman Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus J. Neurosci. 20 2000 9104 9110
14. G.J. Marek, R.A. Wright, D.D. Schoepp, J.A. Monn, and G.K. Aghajanian Physiological antagonism between 5-hydroxytryptamine2A and group II metabotropic glutamate receptors in prefrontal cortex J. Pharmacol. Exp. Ther. 292 2000 76 87
15. R. Martin-Ruiz, M.V. Puig, P. Celada, D.A. Shapiro, B.L. Roth, G. Mengod, and F. Artigas Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism J. Neurosci. 21 2001 9856 9866
16. B.S. Meldrum Glutamate as a neurotransmitter in the brain: review of physiology and pathology J. Nutr. 130 2000 1007S 1015S
17. A. Nakazato, T. Kumagai, K. Sakagami, R. Yoshikawa, Y. Suzuki, S. Chaki, H. Ito, T. Taguchi, S. Nakanishi, S. Okuyama, and Synthesis SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2, 6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists J. Med. Chem. 43 2000 4893 4909
18. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates fourth ed. 1998 Academic Press New York
19. T. Shimazaki, M. Iijima, and S. Chaki Anxiolytic-like activity of MGS0039, a potent group II motabotropic glutamate receptor antagonist, in marble-burying behavior test Eur. J. Pharmacol. 501 2004 121 125
20. T. Yoshimizu, and S. Chaki Increased cell proliferation in the adult mouse hippocampus following chronic administration of group II metabotropic glutamate receptor antagonist, MGS0039 Biochem. Biophys. Res. Commun. 315 2004 493 496